tetradecanoylphorbol acetate has been researched along with relcovaptan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fazzina, G; Gulsen, S; Kleindienst, A; Marmarou, A; Marmarou, CR; Okuno, K; Ozisik, P; Taya, K | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and relcovaptan
Article | Year |
---|---|
The modulation of aquaporin-4 by using PKC-activator (phorbol myristate acetate) and V1a receptor antagonist (SR49059) following middle cerebral artery occlusion/reperfusion in the rat.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 4; Brain Edema; Disease Models, Animal; Enzyme Activation; Indoles; Infarction, Middle Cerebral Artery; Male; Protein Kinase C; Pyrrolidines; Rats; Rats, Sprague-Dawley; Reperfusion; Tetradecanoylphorbol Acetate; Time Factors; Voltage-Dependent Anion Channels | 2008 |